|
【结 构 式】 
|
【药物名称】 【化学名称】3(S)-[2-[5(R)-Methyl-2-oxo-3(S)-(5,6,7,8-tetrahydro[1,8]naphthyridin-2-ylmethylamino)pyrrolidin-1-yl]acetamido]-4-pentynoic acid ethyl ester 【CA登记号】204452-88-0 【 分 子 式 】C23H31N5O4 【 分 子 量 】441.53462 |
【开发单位】Merck & Co. (Originator) 【药理作用】Bone Diseases, Treatment of, METABOLIC DRUGS, Treatment of Osteoporosis, Integrin alphavbeta3 (Vitronectin) Antagonists |
合成路线1
(S)-5-(Hydroxymethyl)-2-pyrrolidinone (I) was condensed with benzaldehyde in the presence of p-toluenesulfonic acid, and the resulting oxazolidine (II) was hydrogenated over Pd/C to afford the N-benzyl pyrrolidinone (III). Treatment of alcohol (III) with I2 and triphenylphosphine gave iodide (IV), which was reduced to the methyl pyrrolidinone (V) employing NaBH4 in HMPT. An azido group was introduced at position 3 of pyrrolidinone (V) by treatment with 2,4,6-triisopropylbenzenesulfonyl azide in the presence of LDA, and the resulting trans-azide (VI) was subsequently epimerized to the cis-isomer (VII) by means of NaOEt in EtOH. Reduction of the azido group of (VII) to the corresponding amine (VIII) was carried out by catalytic hydrogenation over Pd/C, and further treatment with Boc2O provided the tert-butyl carbamate (IX). The N-benzyl group was then removed by means of lithium metal in liquid ammonia to afford (X).
| 【1】 Duggan, M.E.; Hartman, G.D.; Hoffman, W.F.; Meissner, R.S.; Perkins, J.J.; Askew, B.C.; Coleman, P.J.; Hutchinson, J.H.; Naylor-Olsen, A.M. (Merck & Co., Inc.); Integrin antagonists. EP 0934305; US 5981546; WO 9808840 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 38560 | (5S)-5-(hydroxymethyl)-2-pyrrolidinone | 17342-08-4 | C5H9NO2 | 详情 | 详情 |
| (II) | 38561 | (3R,7aS)-3-phenyltetrahydro-5H-pyrrolo[1,2-c][1,3]oxazol-5-one | 103201-79-2 | C12H13NO2 | 详情 | 详情 |
| (III) | 45008 | (5S)-1-benzyl-5-(hydroxymethyl)-2-pyrrolidinone | 125629-91-6 | C12H15NO2 | 详情 | 详情 |
| (IV) | 45009 | (5S)-1-benzyl-5-(iodomethyl)-2-pyrrolidinone | C12H14INO | 详情 | 详情 | |
| (V) | 45010 | (5R)-1-benzyl-5-methyl-2-pyrrolidinone | C12H15NO | 详情 | 详情 | |
| (VI) | 45011 | (3R,5R)-3-azido-1-benzyl-5-methyl-2-pyrrolidinone | C12H14N4O | 详情 | 详情 | |
| (VII) | 45012 | (3S,5R)-3-azido-1-benzyl-5-methyl-2-pyrrolidinone | C12H14N4O | 详情 | 详情 | |
| (VIII) | 45013 | (3S,5R)-3-amino-1-benzyl-5-methyl-2-pyrrolidinone | C12H16N2O | 详情 | 详情 | |
| (IX) | 45014 | tert-butyl (3S,5R)-1-benzyl-5-methyl-2-oxopyrrolidinylcarbamate | C17H24N2O3 | 详情 | 详情 | |
| (X) | 45015 | tert-butyl (3S,5R)-5-methyl-2-oxopyrrolidinylcarbamate | C10H18N2O3 | 详情 | 详情 |
合成路线2
In a related procedure, the protected pyrrolidinone (II) was treated with 2,4,6-triisopropylbenzenesulfonyl azide and LDA to produce a 1:3.2 mixture of isomeric azides (XI) and (XII). After isolation of the major cis-isomer (XII), its catalytic hydrogenation over Pd/C yielded amine (XIII), which was subsequently protected as the N-Boc derivative (XIV). Reductive cleavage of the benzylidene group of (XIV) using Li in liquid ammonia provided the (hydroxymethyl)pyrrolidinone (XV). Reduction of the hydroxymethyl group to the methyl derivative (X) was effected via iodide (XVI) in a similar sequence as above.
| 【1】 Nakanishi, T.; Otsuka, T.; Hashimoto, S.; Okamoto, M.; Muramatsu, Y.; Hino, M.; Hatanaka, H.; WF14865A and B, new cathepsins B and L inhibitors produed by Aphanoascus fulvescens. I. Taxomy, production, purification and biological properties. J Antibiot 2000, 53, 5, 449. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (II) | 38561 | (3R,7aS)-3-phenyltetrahydro-5H-pyrrolo[1,2-c][1,3]oxazol-5-one | 103201-79-2 | C12H13NO2 | 详情 | 详情 |
| (X) | 45015 | tert-butyl (3S,5R)-5-methyl-2-oxopyrrolidinylcarbamate | C10H18N2O3 | 详情 | 详情 | |
| (XI) | 45016 | (3R,6R,7aS)-6-azido-3-phenyltetrahydro-5H-pyrrolo[1,2-c][1,3]oxazol-5-one | C12H12N4O2 | 详情 | 详情 | |
| (XII) | 45017 | (3R,6S,7aS)-6-azido-3-phenyltetrahydro-5H-pyrrolo[1,2-c][1,3]oxazol-5-one | C12H12N4O2 | 详情 | 详情 | |
| (XIII) | 45018 | (3R,6S,7aS)-6-amino-3-phenyltetrahydro-5H-pyrrolo[1,2-c][1,3]oxazol-5-one | C12H14N2O2 | 详情 | 详情 | |
| (XIV) | 45019 | tert-butyl (3R,6S,7aS)-5-oxo-3-phenyltetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-6-ylcarbamate | C17H22N2O4 | 详情 | 详情 | |
| (XV) | 45020 | tert-butyl (3S,5S)-5-(hydroxymethyl)-2-oxopyrrolidinylcarbamate | C10H18N2O4 | 详情 | 详情 | |
| (XVI) | 45021 | tert-butyl (3S,5S)-5-(iodomethyl)-2-oxopyrrolidinylcarbamate | C10H17IN2O3 | 详情 | 详情 |
合成路线3
Pyrrolidinone (X) was alkylated with ethyl bromoacetate to afford ester (XVII), which was further hydrolyzed to acid (XVIII). Its coupling with amino ester (XIX) in the presence of EDC and HOBt furnished amide (XX). The N-Boc group of (XX) was then cleaved with HCl in EtOAc to provide amine (XXI) Aldehyde (XXVI) was obtained by condensation of 2-aminopyridine-3-carboxaldehyde (XXII) with pyruvaldehyde dimethyl acetal (XXIII), followed by partial hydrogenation of the resulting naphthyridine (XXIV) and acid hydrolysis of the dimethyl acetal group. Finally, reductive condensation of amine (XXI) with aldehyde (XXVI) in the presence of sodium triacetoxyborohydride yielded the title compound.
| 【2】 Duggan, M.E.; Hartman, G.D.; Hoffman, W.F.; Meissner, R.S.; Perkins, J.J.; Askew, B.C.; Coleman, P.J.; Hutchinson, J.H.; Naylor-Olsen, A.M. (Merck & Co., Inc.); Integrin antagonists. EP 0934305; US 5981546; WO 9808840 . |
| 【1】 Nakanishi, T.; Otsuka, T.; Hashimoto, S.; Okamoto, M.; Muramatsu, Y.; Hino, M.; Hatanaka, H.; WF14865A and B, new cathepsins B and L inhibitors produed by Aphanoascus fulvescens. I. Taxomy, production, purification and biological properties. J Antibiot 2000, 53, 5, 449. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (X) | 45015 | tert-butyl (3S,5R)-5-methyl-2-oxopyrrolidinylcarbamate | C10H18N2O3 | 详情 | 详情 | |
| (XVII) | 45022 | ethyl 2-[(3S,5R)-3-[(tert-butoxycarbonyl)amino]-5-methyl-2-oxopyrrolidinyl]acetate | C14H24N2O5 | 详情 | 详情 | |
| (XVIII) | 45023 | 2-[(3S,5R)-3-[(tert-butoxycarbonyl)amino]-5-methyl-2-oxopyrrolidinyl]acetic acid | C12H20N2O5 | 详情 | 详情 | |
| (XIX) | 16297 | ethyl (3S)-3-amino-4-pentynoate | C7H11NO2 | 详情 | 详情 | |
| (XX) | 45024 | ethyl (3S)-3-[(2-[(3S,5R)-3-[(tert-butoxycarbonyl)amino]-5-methyl-2-oxopyrrolidinyl]acetyl)amino]-4-pentynoate | C19H29N3O6 | 详情 | 详情 | |
| (XXI) | 45025 | ethyl (3S)-3-([2-[(3S,5R)-3-amino-5-methyl-2-oxopyrrolidinyl]acetyl]amino)-4-pentynoate | C14H21N3O4 | 详情 | 详情 | |
| (XXII) | 45026 | C6H6N2O | 详情 | 详情 | ||
| (XXIII) | 25433 | 1,1-dimethoxyacetone | 6342-56-9 | C5H10O3 | 详情 | 详情 |
| (XXIV) | 45027 | methoxy([1,8]naphthyridin-2-yl)methyl methyl ether; 2-(dimethoxymethyl)[1,8]naphthyridine | C11H12N2O2 | 详情 | 详情 | |
| (XXV) | 45028 | methoxy(5,6,7,8-tetrahydro[1,8]naphthyridin-2-yl)methyl methyl ether; 7-(dimethoxymethyl)-1,2,3,4-tetrahydro[1,8]naphthyridine | C11H16N2O2 | 详情 | 详情 | |
| (XXVI) | 45029 | 5,6,7,8-tetrahydro[1,8]naphthyridine-2-carbaldehyde | C9H10N2O | 详情 | 详情 |